NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000672

Registered date:05/04/2007

Prediction of drug adverse event through gene expression analysis

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedembedded dens molaris
Date of first enrollment2007/01/01
Target sample size20
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Cefcapene Pivoxil Hydrochloride Hydrate 100mg po administration for three times

Outcome(s)

Primary Outcomecorrelation and differences of gene expression between results from basic experiments in vitro and ones in human
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum60years-old
GenderMale and Female
Include criteria
Exclude criteriarenal dysfunction (Creatinin equal or greater than 2.0 mg/dl) liver dysfunction (ALT, AST, T-bil, LDH or ALP are more than two times greater than upper limit of normal range) confirmed or clinically suspected myocardial infarction and/or congestive heart failure prescribed medicines for diabetes mellitus and/or hypertension pasthistory for hypersensitivities and/or allargic reactions against Cefcapene Pivoxil Hydrochloride Hydrate or ingredients of Flomox(R) Past history of hypersensitivities for Cephalosporins

Related Information

Contact

public contact
Name
Address Japan
Telephone 0285-58-7550
E-mail
Affiliation Jichi Medical University SCHOOL AFFAIRS SECTION
scientific contact
Name Akio Fujimura, MD, PhD
Address Shimotsuke-si, Tochigi-ken Japan
Telephone
E-mail
Affiliation Jichi Medical University Clinical Pharmacology